The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Marston's PLC
OTC:MARZF
|
UK |
|
Travis Perkins PLC
LSE:TPK
|
UK |
|
BTCS Inc
NASDAQ:BTCS
|
US |
|
C
|
Corby Spirit and Wine Ltd
OTC:CBYDF
|
CA |
|
H
|
Hang Lung Group Ltd
HKEX:10
|
HK |
|
N
|
Norfolk Southern Corp
DUS:NFS
|
US |
|
Novo Nordisk A/S
CSE:NOVO B
|
DK |
|
K
|
Kyocera Corp
SWB:KYR
|
JP |
|
C
|
CITIC Ltd
OTC:CTPCF
|
CN |
|
Soluciones Cuatroochenta SA
F:5XW
|
ES |
|
Lords & Company Worldwide Holdings Inc
F:4XM
|
CA |
|
Lemonade Inc
F:LE0
|
US |
|
A
|
Aker Solutions ASA
F:1AKA
|
NO |
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
|
Silence Therapeutics PLC
OTC:SLNCF
|
UK |
|
Lake Winn Resources Corp
F:EE1
|
CA |
|
Nikko Co Ltd
TSE:6306
|
JP |
|
P
|
Pure Resources Ltd
ASX:PR1
|
AU |
|
V
|
Victorian Plumbing Group PLC
F:637
|
UK |
|
Frontage Holdings Corp
HKEX:1521
|
US |
|
Schaeffler AG
OTC:SFFLY
|
DE |
|
Cypherpunk Holdings Inc
F:1X0
|
CA |
|
Alkali Metals Ltd
BSE:533029
|
IN |
|
A
|
Anterogen Co Ltd
KOSDAQ:065660
|
KR |
Marston's PLC (MARZF)’s 12-month stock price forecast through October 2027 has a consensus target of $0.8577, implying 46% upside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
MARZF is 0.8577 USD with a low forecast of 0.5662 USD and a high forecast of 0.9632 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 1%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 11%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 3%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 2%.
The compound annual growth rate for Net Income over the next 3 years is -1%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more